 - 0 wk in non-black, HIV-uninfected individuals with serum HCV RNA \< 0 million units/mL   Daclatasvir(Daklinza) plus Sofosbuvir (Sovaldi) - 00 wk   0                                                                    Sofosbuvir/Velpatasvir (Epclusa) - 00 wk                                                                                                                              Elbasvir/Grazoprevir (Zepatier) with weight-based ribavirin for patients with baseline NS0A RA